The bone growth stimulators market size was 1 billion in 2021 and it is anticipated to reach USD 2 billion in 2031, growing at a CAGR of 7.0% from 2022-2031.
Global Bone Growth Stimulators Market report from Global Insight Services is the single authoritative source of intelligence on Bone Growth Stimulators Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Bone Growth stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, and orthopedic fixation. Bone growth stimulators work on all kinds of fractures such as fresh fractures, fractures healing slowly or not at all, and fractures with an elevated risk. It can also be used as supportive therapy after surgery on a fracture and in the corrective osteotomy. Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. Bone growth stimulators are the perfect treatment approach when the patient is not comfortable with the surgical procedure and wants to avoid it. Also, as it fastens the healing process, it helps patients get back to their feet quickly. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. Advantages over surgical procedures, faster recovery time, and increasing patient preference are factors that contribute to the growth of the bone growth stimulator market.
Get Access to A Free Sample Copy of Our Latest Report :https://www.globalinsightservices.com/request-sample/GIS10246
Market Trends and Drivers
The key factor boosting the growth of the market is the growing patient preference for non-invasive and minimally invasive surgical treatments. The demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures. The key advantages of minimally invasive procedures comprise fewer complications, shorter hospitalization, less pain, smaller and more cosmetic incisions, lower risk of infections, reduced postoperative care, and quicker recovery. Minimally invasive procedures make use of advanced technologies to diagnose and treat various diseases, comprising cancer. These procedures are used as an effective approach for removing cancer tumors and lymph nodes without scarring.
Global Bone Growth Stimulators Market Segmentation
The report analyses the bone growth stimulators market based on product, application, end user, and region.
Global Bone Growth Stimulators Market by Product
On the basis of the product, it is segmented into bone growth stimulation devices, bone morphogenic proteins, and platelet-rich plasma. The bone growth stimulation devices segment accounted for the bone growth stimulators market. This can be attributed to the growing geriatric population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures. Adding to that, obesity, smoking, and diabetes, among other factors, can delay or inhibit bone healing after surgery or trauma. The growing incidence of these risk factors will further help the market growth.
Market Players of the Global Bone Growth Stimulators Market
The global bone growth stimulators market report comprises key players such as Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) among others.
Free Customization Available : https://www.globalinsightservices.com/request-customization/GIS10246
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/